NM_024867.4(SPEF2):c.605G>A (p.Arg202Gln) AND Inborn genetic diseases
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Jun 29, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003348448.2
Allele description [Variation Report for NM_024867.4(SPEF2):c.605G>A (p.Arg202Gln)]
NM_024867.4(SPEF2):c.605G>A (p.Arg202Gln)
Condition(s)
- Name:
- Inborn genetic diseases
- Identifiers:
- MeSH: D030342; MedGen: C0950123
-
spike glycoprotein, partial [Infectious bronchitis virus]
spike glycoprotein, partial [Infectious bronchitis virus]gi|2720466761|gb|WZU87050.1|Protein
-
Dyadobacter fermentans strain IGS95 16S ribosomal RNA gene, partial sequence
Dyadobacter fermentans strain IGS95 16S ribosomal RNA gene, partial sequencegi|364521072|gb|JN680262.1|Nucleotide
-
MAG: Pseudoalteromonas sp. UBA6540 UBA6540_contig_30499, whole genome shotgun se...
MAG: Pseudoalteromonas sp. UBA6540 UBA6540_contig_30499, whole genome shotgun sequencegi|2525026023|ref|NZ_DJKO01000226.1 |WGS:NZ_DJKO01|UBA6540_contig_30499Nucleotide
-
actin, partial [Yamadazyma scolyti]
actin, partial [Yamadazyma scolyti]gi|169246607|gb|ACA51233.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: May 1, 2024